Abstract
The status of adipose tissue changes rapidly. From a simple filler tissue, it successively acquires the status of metabolic active tissue, endocrine tissue, plastic tissue, and finally that of a large reservoir of cells suitable for cell therapy and regenerative medicine. All throughout this story, our knowledge has been largely dependent on genetic tools and gene transfer. Now, the time has come where gene transfer in adipose derived cells can be envisioned, not only for understanding the role or importance of one gene, but also to engineer adipose derived cells for the purpose of therapy by delivering secreted products. In this paper, after a brief overview of adipose tissues, a large part will be devoted to the use of virusbased gene transfer in transducing adipose tissue and cells which reside therein. We also critically review the use of adipose “specific” promoters and the applications already described in the literature.
Keywords: Adipose tissue, preadipocytes, adipose derived cells, virus, promoter, shRNA, cell therapy
Current Gene Therapy
Title: Virus-based Gene Transfer Approaches and Adipose Tissue Biology
Volume: 8 Issue: 2
Author(s): Louis Casteilla, Beatrice Cousin, Valerie Planat-Benard, Patrick Laharrague, Mamen Carmona and Luc Penicaud
Affiliation:
Keywords: Adipose tissue, preadipocytes, adipose derived cells, virus, promoter, shRNA, cell therapy
Abstract: The status of adipose tissue changes rapidly. From a simple filler tissue, it successively acquires the status of metabolic active tissue, endocrine tissue, plastic tissue, and finally that of a large reservoir of cells suitable for cell therapy and regenerative medicine. All throughout this story, our knowledge has been largely dependent on genetic tools and gene transfer. Now, the time has come where gene transfer in adipose derived cells can be envisioned, not only for understanding the role or importance of one gene, but also to engineer adipose derived cells for the purpose of therapy by delivering secreted products. In this paper, after a brief overview of adipose tissues, a large part will be devoted to the use of virusbased gene transfer in transducing adipose tissue and cells which reside therein. We also critically review the use of adipose “specific” promoters and the applications already described in the literature.
Export Options
About this article
Cite this article as:
Casteilla Louis, Cousin Beatrice, Planat-Benard Valerie, Laharrague Patrick, Carmona Mamen and Penicaud Luc, Virus-based Gene Transfer Approaches and Adipose Tissue Biology, Current Gene Therapy 2008; 8 (2) . https://dx.doi.org/10.2174/156652308784049354
DOI https://dx.doi.org/10.2174/156652308784049354 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The NK-1 Receptor is Involved in the Antitumoural Action of L-733,060 and in the Mitogenic Action of Substance P on Human Pancreatic Cancer Cell Lines
Letters in Drug Design & Discovery The Re-Emergence of Aerosol Gene Delivery: A Viable Approach to Lung Cancer Therapy
Current Cancer Drug Targets Corticotropin Releasing Factor (CRF) Receptor Signaling in the Central Nervous System: New Molecular Targets
CNS & Neurological Disorders - Drug Targets Clinical Development of 17-Allylamino, 17-Demethoxygeldanamycin
Current Cancer Drug Targets Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer
Current Pharmaceutical Biotechnology Myocardial Regeneration: What is the Best Approach?
Current Cardiology Reviews A Closer Look at Protein Transduction Domains as a Tool in Drug Delivery
Current Nanoscience Genetic and Epigenetic Signatures in Human Hepatocellular Carcinoma:A Systematic Review
Current Genomics Synergistic Interaction of Telomerase-Specific Oncolytic Virotherapy and Chemotherapeutic Agents for Human Cancer
Current Pharmaceutical Biotechnology The Immunoregulatory Protein Human B7H3 is a Tumor-Associated Antigen that Regulates Tumor Cell Migration and Invasion
Current Cancer Drug Targets Drusen in the Peripheral Retina of the Alzheimer’s Eye
Current Alzheimer Research Impact of Cellular Senescence in Aging and Cancer
Current Pharmaceutical Design Possible Role of DNA Methylation in the Induction of Systemic Lupus Erythematosus
Current Rheumatology Reviews Biology of Transforming Growth Factor-β Signaling
Current Pharmaceutical Biotechnology From Peptides to Small Molecules: An Intriguing but Intricated Way to New Drugs
Current Medicinal Chemistry Targeting Histone Deacetylases in Neuroblastoma
Current Pharmaceutical Design “Virostatics” as a Potential New Class of HIV Drugs
Current Pharmaceutical Design Stem Cell Fate Decisions: The Role of Heparan Sulfate in the Control of Autocrine and Paracrine Signals
Current Stem Cell Research & Therapy HPV and Therapeutic Vaccines: Where are We in 2010?
Current Cancer Therapy Reviews Phosphopeptides - Chemical Synthesis, Analysis, Outlook and Limitations.
Current Organic Chemistry